Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The allegations made about the conception and establishment of the INTERGROWTH-21st research project are unfounded and without substance. Oxford University has its own robust internal review procedures which meet the highest academic standards on research conduct. Three separate investigations, in 2008, 2009 and 2011, have concluded there was no misconduct. These findings have been shared in detail with WHO, which has declared on three separate occasions that the matter is closed. The WHO’s recent review has not considered any material which has not already been thoroughly investigated by the University.

The results of the INTERGROWTH-21st Project have proved invaluable in highlighting the problems facing some of the most vulnerable infants in the world.  For example, a 2015 study by Johns Hopkins University concluded that 24% of all newborns in developing countries, assessed using the INTERGROWTH-21st Newborn Size Standards, are malnourished at birth. Hence, Oxford University is working closely with regional and country offices of WHO to disseminate the international standards arising from the project. 

In June 2016, WHO recommended the use of the INTERGROWTH-21st Newborn Size Standards to assess babies born to mothers who might have been infected with the Zika virus in pregnancy; these standards have also been adopted by CDC (Centers for Disease Control and Prevention).  In addition, this month, Sri Lanka became the first country in the world to adopt the INTERGROWTH-21st Postnatal Growth Standards for Preterm Infants.

Oxford University hopes to work further with WHO on the adoption of the project’s much-needed clinical tools and will vigorously defend the high standing and reputation of our researchers.

For further information, contact the News and Information Office on 01865 280528 or email news.office@admin.ox.ac.uk

Similar stories

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).